Antonio
González Martín
Consultor Médico
![Foto de Antonio](/img/nophoto.png)
![Foto de Hannover Medical School](/img/noimage_org.png)
Hannover Medical School
Hanóver, AlemaniaPublications en collaboration avec des chercheurs de Hannover Medical School (1)
2023
-
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Annals of Oncology, Vol. 34, Núm. 8, pp. 681-692